These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34332718)

  • 1. Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma with Intra-atrial Tumor Extension: Imaging Response and Oncologic Outcomes.
    Kolarich A; Frangakis C; Yarchoan M; Hong K; Georgiades C
    J Vasc Interv Radiol; 2021 Aug; 32(8):1203-1208.e1. PubMed ID: 34332718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization.
    Moschouris H; Malagari K; Papadaki MG; Kornezos I; Stamatiou K; Anagnostopoulos A; Chatzimichael K; Kelekis N
    Diagn Interv Radiol; 2014; 20(2):136-42. PubMed ID: 24317334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
    El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
    Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Transarterial Chemoembolization Improves Survival After Liver Transplant in Patients With Hepatocellular Carcinoma.
    Werner JD; Frangakis C; Ruck JM; Hong K; Philosophe B; Cameron AM; Saberi B; Gurakar A; Georgiades C
    Exp Clin Transplant; 2019 Oct; 17(5):638-643. PubMed ID: 30251938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging Hepatocellular Carcinoma to Transplant: Transarterial Chemoembolization Response, Tumor Biology, and Recurrence after Transplantation in a 12-Year Transplant Cohort.
    Sandow T; Pavlus J; Field D; Lacayo E; Cohen E; Lynskey G; Caridi T; Buckley D; Cardella J; Kallakury B; Spies J; Kim AY
    J Vasc Interv Radiol; 2019 Jul; 30(7):995-1003. PubMed ID: 31109853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
    Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
    J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Treatment Response to Intra-arterial Therapies for Hepatocellular Carcinoma with the Use of Supervised Machine Learning-An Artificial Intelligence Concept.
    Abajian A; Murali N; Savic LJ; Laage-Gaupp FM; Nezami N; Duncan JS; Schlachter T; Lin M; Geschwind JF; Chapiro J
    J Vasc Interv Radiol; 2018 Jun; 29(6):850-857.e1. PubMed ID: 29548875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
    Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
    Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolization experience for advanced hepatocellular carcinoma with right atrial tumor thrombus.
    Zhu L; Yang R; Zhu X
    J Cancer Res Ther; 2019; 15(2):305-311. PubMed ID: 30964102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Validation of Drug-Eluting Beads Transarterial Chemoembolization of Hepatocellular Carcinomas in Living Donor Liver Transplantation.
    Tong YS; Huang TL; Chen TY; Tsang LLC; Ou HY; Yu CY; Hsu HW; Xiong LW; Liao CC; Eng HL; Chen CL; Cheng YF
    Transplant Proc; 2018 Nov; 50(9):2622-2625. PubMed ID: 30401362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
    Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
    J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
    Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
    J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncontrast chest computed tomography immediately after transarterial chemoembolization in patients with hepatocellular carcinoma: clinical benefits and effect of radiation reduction on image quality in low-dose scanning.
    Choi JI; Kim HB; Kim MJ; Lee JS; Koh YW; An SB; Ko HK; Park JW
    Eur J Radiol; 2011 Nov; 80(2):e188-94. PubMed ID: 21708441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of n-butyl cyanoacrylate to classic transarterial chemoembolization may improve the radiological response in patients with hepatocellular carcinoma.
    Monsignore LM; Elias-Junior J; Muglia VF; Teixeira AC; Mente ED; Martinelli Ade L; Abud DG
    Clinics (Sao Paulo); 2015 Dec; 70(12):781-9. PubMed ID: 26735217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.
    Kim HC; Lee JH; Chung JW; Kang B; Yoon JH; Kim YJ; Lee HS; Jae HJ; Park JH
    J Vasc Interv Radiol; 2013 Feb; 24(2):274-83. PubMed ID: 23369561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.
    Adhoute X; Pénaranda G; Raoul JL; Pietri O; Bronowicki JP; Castellani P; Perrier H; Monnet O; Bayle O; Oules V; Pol B; Beaurain P; Muller C; Cassagneau P; Bourlière M
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1414-1423. PubMed ID: 31045613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Patients with Hepatocellular Carcinoma Treated with Conventional Transarterial Chemoembolization Using Guidance Software.
    Miyayama S; Yamashiro M; Sugimori N; Ikeda R; Okimura K; Sakuragawa N
    J Vasc Interv Radiol; 2019 Jan; 30(1):10-18. PubMed ID: 30580809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma.
    Kono Y; Lucidarme O; Choi SH; Rose SC; Hassanein TI; Alpert E; Mattrey RF
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):57-65. PubMed ID: 17296705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
    Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
    J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.